Please check your internet connection and try again.
# IV Hydrocortisone for Acute Asthma
## Overview
Hydrocortisone is a short-acting systemic corticosteroid used when the oral route is compromised or ineffective in severe, refractory acute asthma exacerbations. Note: Methylprednisolone is often preferred in clinical practice due to its higher relative glucocorticoid potency and lower mineralocorticoid activity.
## Primary Indications
* Severe acute asthma exacerbation (status asthmaticus) in patients unable to tolerate oral intake or with poor GI absorption.
## Adult Dosing
* **Initial Dose:** 100 mg IV bolus.
* **Maintenance:** 50–100 mg IV every 6–8 hours.
* **Maximum:** No strict maximum in acute stabilization, but systemic exposure should be minimized to the shortest duration necessary. Transition to oral prednisone as soon as feasible.
## Pediatric Dosing
* **Initial Dose:** 2–4 mg/kg/dose IV (stat).
* **Maintenance:** 2–4 mg/kg/dose IV every 6 hours.
* **Maximum:** 100 mg/dose.
* **Note:** Dosing varies widely by local institutional protocol; confirm with pediatric guidelines (e.g., NAEPP or GINA).
## Dose Adjustments
* **Hepatic/Renal Impairment:** No specific dose adjustment generally required for acute, short-term treatment.
* **Chronic Use:** Longer courses require tapering to prevent HPA axis suppression.
## Contraindications
* Systemic fungal infections.
* Hypersensitivity to hydrocortisone or any component of the formulation.
## Adverse Effects
* **Common:** Hyperglycemia, agitation, insomnia, mood swings, increased appetite.
* **Rare/Serious:** Hypertension, fluid retention, hypokalemia, peptic ulcer disease, increased susceptibility to secondary infections.
## Key Drug Interactions
* **CYP3A4 Inducers (e.g., phenytoin, phenobarbital, rifampin):** May decrease hydrocortisone efficacy.
* **NSAIDs:** Increased risk of gastrointestinal ulceration/bleeding.
* **Diuretics:** Potential for additive hypokalemia.
## Monitoring
* **Clinical:** Respiratory rate, oxygen saturation, work of breathing, and peak flow (PEF).
* **Laboratory:** Blood glucose (frequent monitoring in diabetics), electrolytes (potassium), and blood pressure.
## Clinical Pearls
* **Route:** Transition to oral therapy (prednisone/prednisolone) as soon as the patient can tolerate oral medications; systemic steroids in asthma are rarely required IV unless the patient is intubated or severely vomiting.
* **Onset:** IV corticosteroids are not immediate; clinical benefit typically takes 4–6 hours to manifest. Ensure concomitant use of inhaled short-acting beta-agonists (SABA) and ipratropium.
* **Physiological Effect:** Hydrocortisone has significant mineralocorticoid activity (sodium retention/potassium wasting) compared to other corticosteroids like dexamethasone or methylprednisolone.
***
**Educational Disclaimer:** This information is for educational purposes only. Clinical practice varies by institution; always verify current prescribing information, institutional protocols, and patient-specific factors before administration. Consult a physician or clinical pharmacist for final dose verification.
